Latest / The William Blair Thinking Podcast
Biotech Breakthroughs - Advancing Diabetes Treatments: Exploring GLP-1s and Beyond
Tim Lugo speaks with fellow equity research analysts Margaret Kaczor Andrew and Andy Hsieh about the GLP-1 drug class and its impact on the management of obesity, including potential read-throughs to the medtech and the therapeutics sector.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.